High total metabolic tumor volume on 18F-FDG-PET/CT correlates with lack of immune response in advanced melanoma patients treated with pembrolizumab.Odrade Gondry, Marleen Keyaerts, Emma Daeninck et al.|Unknown|2020Cited by 0